The platform provides the expertise, guidance and infrastructure required to respond to the diverse regulatory and technical challenges of Wyss Zurich projects in the field of Regenerative Medicine. It aims to support Wyss Zurich projects in the efficient translation of biomedical preclinical research into applied regenerative therapies, and to accelerate entry of innovative treatments into clinical trials. In particular, it addresses the existing and increasing demand for the clinical application of newly developed drugs and transplant products (TpPs, also called Advanced Therapy Medicinal Products, ATMPs).

In addition, Wyss Zurich has established product development processes in alignment with the international standard ISO 13485 to support and accelerate the growing number of medical device projects. Application of these quality procedures aims to ensure that Wyss Zurich projects, which develop medical devices, also meet the regulatory requirements.

Support is provided through the following departments, infrastructure and services:

Manufacturing (GMP)

  • 800 sqm facility; including clean rooms of 200 sqm (GMP grade A, B, C, D)
  • Five separate GMP grade B and C clean rooms for handling different kinds of cell culture manufacturing processes for drugs and TpPs/ATMPs
  • Grade D clean room designed for preparation and packaging
  • Qualified autoclave for steam sterilization of equipment and material
  • Qualified equipment for the production of drugs and TpPs/ATMPs (e.g. particle-monitored class II safety cabinets, CO2 incubators, refrigerators, freezers, refrigerated centrifuges, inverse microscopes, CliniMACS Prodigy® for automated cell processing, NucleoCounter for automated cell counting, etc.)
  • Continuous monitoring of clean room parameters (airborne particles, differential pressure, temperature, humidity) of the safety cabinets, incubators and storage locations
  • Equipment qualification and technical process verification
  • Manufacturing of products under GMP conditions for clinical supply

Quality Management (GMP)

  • Swissmedic manufacturing license and Certificate of GMP Compliance for drugs and investigational drugs (including aseptically manufactured products)
  • Swissmedic manufacturing license and Certificate of GMP Compliance for investigational cell therapy products, investigational tissue products and investigational ex vivo gene therapy products
  • Certified Quality Management System (e.g. Master Standard Operating Procedures, Deviation Management, Change Control Management, Risk Management, etc.)
  • Review and approval of all GMP/GDP-relevant documents in order to guarantee compliance with GMP/GDP regulations
  • Assurance of the quality system and inspection readiness
  • Quality assurance of the GMP standards of the Wyss facility including all departments and project teams (e.g. training status etc.)
  • Advice for project teams on scientific compliance from senior GMP experts (project-specific strategies)
  • Supplier selection and qualification (external audits)
  • Compliance direction for all GMP/GDP-relevant issues
  • Assurance of batch release process for clinical trials

Quality Control (GMP)

  • Analytical batch release and in-process control for clinical supply, stability studies, transport studies, process verification runs, etc.
  • Release of raw material and consumables
  • Review and approval of GMP documentation
  • QC laboratories with qualified equipment for the analytical testing of drugs and TpPs/ATMPs (flow cytometer, hematology analyzer, microscopes, endotoxin measuring device, thickness measuring system, etc.)
  • Environmental monitoring of the GMP facility (airborne particles, airborne microorganisms, surface microorganisms, including identification of germs)
  • Microbiological assays (e.g. sterility and growth promotion assay)
  • Optimization of analytical methods including method verification and validation
  • Equipment qualification
  • Initial qualification and continuous training of personnel

Hygiene (GMP)

  • Hygiene assurance of the clean room at the Wyss Zurich facility
  • Responsible for the cleaning standard of the clean rooms and laboratories
  • Initial qualification and continuous training of personnel

Biobank (GMP)

  • Qualified cryo infrastructure for controlled freezing and storage of e.g. therapeutic relevant cell and tissue samples (e.g. master and working cell bank) in the vapor phase of liquid nitrogen
  • -80°C freezers for sample storage
  • Cryogenic workbench
  • Qualified sample management

Good Distribution Practice, GDP

  • Review and approval of GDP documentation
  • Established collaboration with GDP-compliant couriers
  • Swissmedic distribution license (Certificate of GDP Compliance) for drugs and TpPs/ATMPs

ISO 13485 for Medical Devices

  • Quality Management processes according to ISO 13485 for development of medical devices
  • Templates for technical documentation required for regulatory purposes
  • Training and support of medical device projects in Quality Management and regulatory aspects

Regenerative Medicine Technologies factsheet

Martin Kayser
CTO and Qualified Person


Having more than 20 years of experience in the field of pharmaceutical industry, Martin Kayser, leads the Regenerative Technology Platform of Wyss Zurich. As the CTO and Qualified Person he is responsible for the quality, safety and efficacy of the products produced in the GMP Facility. In addition, his focus lies on scientific and technological issues within the Wyss Zurich platform and is primarily concerned with long-term and "big picture" issues while still having deep technical and regulatory knowledge.
Martin has studied Environmental Sciences at ETH Zurich and received his PhD in molecular science at the Institute of Microbiology (ETH Zurich) where he worked on the biodegradation pathways of halogenated hydrocarbons in different bacteria. He has a strong background in working in strictly regulated (GMP, GDP, GLP) environments as he worked in different positions in the pharmaceutical industry. He started as the head of a microbiological quality control lab and worked as the head of quality control for several years. In the function of the Qualified Person he worked in spin-off companies and finally as the head of GMP at the Swiss Center for Regenerative Medicine at the University Hospital Zurich.


Monika Bauer
Quality Control


Monika Bauer joined Wyss Zurich in 2016. As Scientific Associate in Quality Control her focus is on flow cytometry and bioassays. She received her diploma in chemistry from the University of Freiburg and did her doctorate in the field of viral immunology (Institute of Microbiology and Hygiene, Freiburg). After postdoctoral research at the Free University of Berlin investigating mechanisms of peripheral pain she joined Cytos Proteome Therapeutics as Senior Scientist working on drug discovery. In 2002 she moved to Cytos Biotechnology. There she led the Flow Cytometry Unit and co-invented the eMAB® platform used for the development of fully human therapeutic antibodies. In 2010 Monika was hired as Senior Scientist Specialist by Intercell to continue her work on human therapeutic antibodies resulting in numerous publications and patents.


Michaela Binal
Head of Microbiology / Hygiene Officer


Michaela Binal is Head of Microbiology and Hygiene Officer at the Regenerative Medicine Technologies Platform since June 2022 and responsible for all microbiological activities such as the environmental monitoring in the clean room until class A, extensive monitoring during Media Fill, sterility analysis and growth promotion tests of the Wyss Zurich GMP facility. She is leading the microbiology team and supporting projects by performing QC analyses like in-process control, incoming good inspection and final product release assays. In 2016 she joined Wyss Zurich as a microbiology technician in the Quality Control department. Michaela obtained her microbiology education as a biotechnological assistant at the Justus-von-Liebig-Schule in Waldshut in 2013 and worked as a lab technician in a Swiss Food Company, where she was involved in various activities such as raw material, in-process, manufacturing or packaging controls. Already there, she was performing the microbiological monitoring in a regulated environment.


Lea Dändliker
Production & Stock Assistant


Lea Dändliker joined Wyss Zurich in November 2018 as a Production Assistant and Stock Manager. Lea is responsible for the projects equipment and production process of Wyss Zurich projects. Her apprenticeship as a druggist gives her the knowledge in handling with medicine and merchandise management system. In 2013, Lea decided to catch up on the BMS in Zurich (Berufsmaturitätsschule) in the fields health and social, which gives her a fundamentally knowledge in biology science. Lea made her first working experience in laboratories when she was a member in the aseptic laboratory of KAZ (Kantonsapotheke Zurich) for two years preparing chemotherapy and other sterile products. After a long travel in 2017, she decided to move back into aseptic work.


Em Dang
Assistant Quality Management


Em Dang joined Wyss Zurich as Assistant for the Quality Management group in March 2016. She is responsible for the administration of the document and training management system. In addition, she supports the warehousing team. Em was educated as a bookseller followed up by advanced training at commercial school. She has long-standing experience in administration and customer relationship management.


Martina Dragic
Senior Quality Manager


Martina Dragic joined Wyss Zurich as Quality Manager Projects in October 2020. In May 2021 she took over the role as Senior Quality Manager. She supports all divisions of the Regenerative Medicine Technologies Platform to ensure GMP compliance and guarantee the quality, safety, and efficacy of the manufactured products and to maintain and further develop the quality management system of the GMP facility. After her apprenticeship as a chemical lab technician, Martina obtained a Bachelor in Biotechnology, majoring in Pharmaceutical Technologies, at the Zurich University of Applied Sciences (ZHAW) in 2008. After graduating, she worked for nine years in the Radiopharmaceutical Industry, where she gained extensive experience in the fields of production, quality control, quality management, and regulatory affairs. From 2017-2019, Martina was part of the Wyss Zurich family, where she acted as GMP Officer Production, an important interface between the production and the quality management group. Before returning to Wyss Zurich, she succeeded in a nine-month position as Head of GMP production in a Biotech Startup company.


Gabriela Gächter
Head of Quality Management


Gabriela Gächter joined Wyss Zurich in 2015 as Head of Quality Management. In this role she is responsible to maintain and further develop the quality management system of the GMP facility in order to guarantee the quality, safety and efficacy of the products manufactured, and to ensure compliance with regulations. Gabriela studied Pharmaceutical Sciences at the ETH Zurich and obtained her Swiss Federal Diploma for Pharmacists in 1994. She has more than 15 years of experience in GMP environment within the Pharmaceutical Industry. During her industrial career she gained expertise in all aspects of quality management with a special focus in non-compliance investigation, change control, and qualification and validation. She has actively participated in various health authority inspections (e.g. Swissmedic, EMEA, FDA, ANVISA).


Lisa Grabner
Quality Manager Projects


Lisa Grabner joined Wyss Zurich in September 2017. In her role as Quality Manager Projects she supports production and project teams to ensure GMP compliance and to guarantee quality, safety and efficiency of the manufactured products. Lisa studied Biology at the University of Vienna and did research for her diploma thesis at the Clinical Institute of Pathology of the Medical University of Vienna. After graduating in 2012 she started her career in the Pharmaceutical Industry as part of the quality assurance team. In her position she worked closely with the manufacturing department to ensure compliance of the production area, process and products and to further improve quality standards. Lisa was mainly responsible for CAPA management, change control and risk management.


Ursina Graf
Quality Manager


In her role as Quality Manager Ursina Graf supports the core competences of quality management of the Wyss Zurich platform for Regenerative Medicine Technologies, such as internal auditing, document management, non-conformance handling, change control and risk management. She was educated as druggist and has more than 10 years of work experience in strictly regulated environment (GMP, GLP) in microbiological quality control. Ursina holds a TÜV Certification in Quality Management and did advanced trainings in various GMP topics with special focus in auditing, microbiology and hygiene in GMP environment. She joined the former Swiss Center for Regenerative Medicine in 2010 as manager of the microbiology lab and developed into the role as Quality Manager of Wyss Zurich in 2015.


Mirjam Hediger
GMP Officer Quality Control


Mirjam Hediger joined the Wyss Zurich Regenerative Medicine Technologies Platform as GMP Officer Quality Control in September 2017. In her function, she represents an important interface between Projects Teams, QC and QM. Since January 2018 she is also Deputy Head of Quality Control. Mirjam obtained a Bachelor in Chemistry with specialisation in Biochemistry at Zurich University of Applied Sciences (ZHAW) in 2009. Afterwards Mirjam worked in the Quality Control Laboratory of a pharmaceutical company. From 2012 to 2017 she was deputy manager for raw materials and monitoring in the Chemical Quality Control unit of CSL Behring in Bern. Mirjam has a lot of experience working according to different pharmacopoeias in a GMP environment, as well as in handling changes, deviations and writing SOPs.


Simon Hostettler
Scientific Associate Quality Control


Simon Hostettler joined the Wyss Zurich Regenerative Medicine Platform in March 2018. As Scientific Associate in Quality Control, he is responsible for the implementation of new analytics, method and process validation as well as instrument qualification. Simon studied Molecular Biology at the University of Basel, which he concluded with a Master’s Degree in 2010. Before assuming his current role, Simon gained experience in a regulated environment within a leading diagnostic company in Assay Development in the role of a Scientist.


Santipab Isenegger
Microbiology Technician QC


Santipab Isenegger joined the Wyss Zurich Regenerative Medicine Platform in April 2020 as a Microbiology Technician in the Quality Control department. He is conducting diverse microbiological routine tasks, including the environmental monitoring of the Wyss Zurich GMP facility. Besides, he is supporting projects by performing QC analyses such as in-process control and end product assays.

Before joining the Wyss Zurich Team, Santipab worked many years as a product specialist in PCR Reagent Operation at Roche Diagnostics in Rotkreuz. In this position, he gained great experience not only in lab work but in GMP documentation as well. He completed his education as a food technologist at Emmi AG in Luzern in 2005.


Irène Jost
Quality Manager Medical Devices


Irène Jost joined Wyss Zurich in May 2020. In her role as a Quality Manager Medical Devices, she is responsible for maintaining and developing the ISO 13485 quality management system. Furthermore, she supports the Wyss Zurich projects in their product design and development according to ISO standards. Additionally, she focuses on software medical devices conforming to IEC 62304. After finishing her Bachelor’s degree in Life Science Technologies in Medical Informatics in 2009, Irène started as a Software Engineer for CISTEC AG. In 2012, she completed her Master’s in IT project management. Her master thesis in quality management paved the way for a job as a QMB/BdoL. In this position, she was leading a project team to set up a quality management system for ISO 13485. She gained not only valuable experience in maintaining a QMS and risk management but also in regulatory affairs for medical devices.


Eldina Kovac
Stock Manager / Administration


Eldina Kovac is a Pharmaceutical Assistant with commercial education, responsible for the warehouse management and administrative duties. The proven experience in pharmaceutical warehousing combined with her administrative education, makes her a valuable member of the GMP team. Her long gained experience in different teams brings a value to the translation of academic projects.


Sabrina Küpfer
Project Manager GMP Process Development


Sabrina Küpfer joined Wyss Zurich in October 2019 as a Project Manager GMP Process Development. She is responsible for all GMP-related aspects of production and serves as a valuable interface between production and the quality department. Additionally, she is responsible for project evaluation and drawing up quotes, in cooperation with Wyss CTO. Sabrina received a Master's degree in Molecular Technologies with specialization in Chemistry from the University of Applied Sciences Northwestern Switzerland (FHNW) in 2012. She worked as a Validation Specialist in the Manufacturing, Science and Technology Department at F. Hoffmann- La Roche AG for 6 years, where she gained expertise in GMP-production (sterile), regulatory compliance, qualification, validation and monitoring (critical utilities, cleanroom). She has participated in various health authority inspections (e.g. FDA, RHI, ANVISA).


Pedro Lorca
Senior Quality Manager


Pedro Lorca joined Wyss Zurich as Senior Quality Manager in October 2021. He supports all divisions of the Regenerative Medicine Technologies Platform to ensure GMP compliance and guarantee the quality, safety, and efficacy of the manufactured products and to maintain and further develop the quality management system of the GMP facility.
Pedro studied Pharmaceutical Sciences at the ETH Zurich and obtained his Diploma for Pharmacist in 1991. He has more than 25 years of experience in GMP environment within the Pharmaceutical Industry. During his industrial career, he gained expertise in aspects of R&D of solid dosage forms, including the manufacture of material for clinical studies; manufacturing of solid and sterile dosage forms; manufacturing of soft gelatin capsules; quality management with a special focus on classic active pharmaceutical ingredients, in handling customer claims, change control, and qualification of suppliers. In the past eight years, he acted as responsible person for GMP and GDP in a Swiss medium-sized company, specialized in the supply and distribution of raw materials for the pharmaceutical and food industries, and was responsible for health authority inspections (e.g. Swissmedic, BGV).


Christoph Meienhofer
Production Assistant


Christoph Meienhofer joined Wyss Zurich in April 2015 as a member of the production translation team. Due to his technical flair, he is responsible for the maintenance, qualification and validation of equipment and production process of Wyss Zurich projects. Thanks to his long experience in the pharmaceutical regulatory environment, he brings the knowledge to the translational project. He gained his experience during his eight years in the production department of a world leading vaccines company Crucell (Johnson&Johnson) as a shift leader in GMP cleanroom production. He was responsible for pharmaceutical production, monitoring and maintenance of Hepatitis A vaccines. He started his career with a degree in nutrition technology and did by work an education as a technical merchant. In this phase, he gained experience in analytical and R&D processes.


Kamal Mettler
Microbiology Technician QC


Kamal Mettler joined the Wyss Zurich Regenerative Medicine Platform in November 2021. As a Microbiology Technician in the Quality Control department, he is responsible for various analytical and microbiological routine tasks. In addition, he is in charge of the environmental monitoring of the Wyss Zurich GMP facility. Before joining the Wyss Zurich Team, Kamal worked as a Flexodrucker at Permapack AG in Rorschach, whereupon he decided to study Chemistry. In 2021, he graduated with a Bachelor of life sciences in Chemistry with Specialization in Biological Chemistry at the University of Applied Sciences (UAS) Zurich. 


Janine Muller
Quality Manager


Janine Muller is the main responsible for the training system of the Wyss Zurich platform for Regenerative Medicine Technologies. In addition, she supports further core competences of quality management such as document management, internal auditing, non-conformance handling, change control and risk management. Janine has longstanding experience in administration and organization of large business units with specific focus in university and medical environment. She holds a CAS in Quality Management from the ZHAW School of Engineering and did advanced trainings in various GMP topics and project management. She joined the former Swiss Center for Regenerative Medicine in 2009 as lead of the administration office and project coordinator, and developed into the role as Quality Manager of Wyss Zurich in 2015.


Monia Saglini
Quality Manager Projects


Monia Saglini joined Wyss Zurich as Quality Manager Projects in November 2020. In her role, she supports production and project teams to ensure GMP compliance and guarantee the quality, safety, and efficiency of the manufactured products.

Monia received her MSc in Molecular Biology from the University of Basel in 2013. After graduating, Monia joined an academic research group, where she was involved in the translation of the production process of ATMPs from R&D to GMP and their production for Phase I clinical trials. In October 2016, Monia joined the Wyss Zurich family as Head of GMP Production for the project “denovoSkin”. For three years, she led the production of autologous bioengineered skin grafts for Phase II clinical trials. Later she took over the position of Senior GMP Production Officer within the project, focusing more on the technical supervision of the team and quality assurance. During this time, Monia gained broad expertise in GMP production and further educated herself in the fields of validations, qualifications as well as quality assurance.


Claudia Schäfer
GMP Officer Production


Claudia Schäfer joined Wyss Zurich in June 2019 as GMP Officer Production. In her position, she is responsible for all GMP related aspects in the production and builds an important interface between production and quality department. Claudia studied bioprocess engineering with the specialization in biotechnology at the Technical University Dresden and obtained her Engineer Diploma (Dipl.-Ing. (MSc)) in 2003. She has more than 10 years’ experience in GMP-regulated industrial production environment and starts her career at the pharmaceutical company GlaxoSmithKline Biologicals. During her further career, she continued working for drugs and API producing companies. Claudia gained expertise in quality management, GMP-production (sterile and non-sterile) regulatory compliance and validation.


Ulrike Schmidt
Head of Quality Control


Ulrike Schmidt is Head of Quality Control at the Wyss Zurich since 2016. Her focus is set on elevating the microbial quality in the cleanrooms, and building solid analytical technologies to implement new modalities. She is managing diverse project teams and contract laboratories and is also responsible for the In Process Control. Ulrike has gathered an extensive bio‑analytical development experience. The last ten years, she worked as Associated Director in the Quality Control in the Pharmaceutical Industry to validate and transfer new analytical methods of biologics for release tests and stability studies according to cGMP. At the same time she was responsible for managing projects of the clinical phase I and II, and technical transfers to commercial sites. Previously, Ulrike worked for 4 years as a Post-Doc at the University of Zurich in the Department of Plant and Microbial Biology after achieving her PhD in Molecular Biology at the Max-Planck-Institute of molecular Plant Physiology in Potsdam, Germany. Originally she started her career at the Technical University of Berlin, Germany, by achieving her diploma and governmental certificate in Food Chemistry.


Miriam Skilandat
Head Medical Devices


Miriam Skilandat joined the Medical Device Unit at Wyss Zurich in April 2018 as a quality manager and has been leading the unit since January 2021. She is responsible for the maintenance and development of the ISO 13485-based quality management system and for supporting Wyss Zurich projects in quality and regulatory aspects of design and development. Miriam obtained a Master’s degree in Molecular Life Sciences at the University of Lübeck. After graduating with a PhD in bioinorganic chemistry from the University of Zurich in 2014, Miriam joined Roche Diagnostics as a Product Quality Engineer for in-vitro-diagnostic instruments. In this role, she gained substantial experience in GMP, GDP, change and deviation management as well as trend and statistical process analysis. Since 2019, Miriam is a certified professional for medical software (CPMS).


René Stenger
QP GDP / Head of Production


René Stenger is the Head of Production and Qualified Person for Good Distribution Practices (GDP) at Wyss Zurich. As a chemist with a postgraduate “Diplom” in Medicine-Technology-Management (Bern University of Applied Sciences), he has long lasting experience in the highly regulated industrial environment of medical devices and pharmaceuticals. In his former positions in several spin-off companies, as well as the Swiss Center for Regenerative Medicine of the University Hospital Zurich, he accompanied various translational projects in the field of regenerative medicine, e.g. a First-In-Man clinical study to evaluate the safety of autologous tissue-engineered dermal and dermal-epidermal skin substitutes for the treatment of large deep partial- and full-thickness skin defects in Children and Adolescent (University Children’s Hospital Zurich) and an open, monocentric phase I/II trial to assess the safety and feasibility of the autologous SCRM001_TEVG in pediatric patients with a congenital single ventricle heart defect.


Daniela Stoisor
Administrative Assistant


Daniela Stoisor joined the Regenerative Medicine Technologies Platform of Wyss Zurich as Administrative Assistant in July 2015. She is responsible for office management and administrative coordination. Daniela studied foreign languages and has a longstanding experience in administration and customer relationship management.


Dario Studer
Scientific Associate Quality Control / Lab Technician Biobank


Dario Studer joined Wyss Zurich in May 2018, where he is currently working as a Scientific Associate in Quality Control and Lab Technician at the Cell- and Tissue Biobank (CTBB) of the Regenerative Medicine Technologies Platform. His main tasks are to perform routine analytical methods for QC including In-Process Control (IPC) and product release assays. Dario is also involved in implementation tasks in the QC Lab like method validation and instrument qualification, moreover he provides services for the Biobank. Previously, during his Bachelor studies at the Zurich University for Applied Sciences (ZHAW), he participated in the development of preclinical cell-based-assays. Dario gathered as well experience in Clinical Study execution at the Swiss TPH.


Iris Szankowski
HR Manager & Platform Coordinator


With her scientific background and long lasting experience in project management, Iris Szankowski is the Coordinator of the Regenerative Medicine Platform of Wyss Zurich. Iris studied Biology at the Leibniz University Hannover, Germany, received her “Diplom” degree in 1998 and her Ph.D. (Dr. rer. nat.) in 2002. In the same year she was appointed as a Junior Professor at the Leibniz University and led a research group in the field of plant biotechnology and genetic engineering. From 2008 to 2010 she continued her research in plant genetic engineering at the Phytopathology group of the ETH Zurich and started with project management. In 2011 she joined the Hoerstrup research team at the University of Zurich. As a project manager, she coordinated large consortia, including three EU FP7 projects and managed several projects funded by the SNF, KTI and foundations. At Wyss Zurich she is the interface between the University of Zurich and ETH Zurich and leads the financial, administrative and human resources related operations.


Mirjam Tehlar
Quality Manager


Mirjam Tehlar joined the ISO-Quality Management Team of Wyss Zurich in April 2020. She is responsible for supporting Wyss Zurich Medical Device projects with its ISO-Quality Management System according to the ISO standards. Mirjam holds an MSc in Human Movement Science and Sport from ETH Zurich (2008). During her master’s studies, she worked on a project to measure the healing phases of a Supraspinatus tendon after surgery at the Biomechanics Lab of the Uniklinik Balgrist. Mirjam worked for nine years at Geistlich Pharma AG, where she was part of the international team for bone substitute for dental and maxillofacial surgery. Further experience she gained with the work as Performance Manager at a health insurance company in the field of off-label medication.


Steffen Zeisberger
Head Cell- & Tissue Biobank (CTBB)


Steffen joined the Regenerative Medicine Platform in 2009. The GMP facility, which became the Regenerative Medicine Platform Wyss Zurich in 2015. He is leading the Cell- and Tissue Biobank (CTBB) and is responsible for the Supplier Qualification Assurance (SQA). He earned a doctorate (Dr. rer. nat.) from the ETH Zurich, Switzerland. Steffen has built up the CTBB with validated workflows ensuring an uninterrupted cooling chain, which applies a qualified central IT-system. Steffen is representing CTBB in various national and international associations, such as SBP, GDK e.V. and ESBB. In order to assure supplier conformity Steffen is leading audits at external stakeholders, being accountable for quality assurance agreements.
Steffen is co-founder of the International Placenta Stem Cell Society (IPLASS), founder and leader of the NTN-biotechnet platform “Regenerative Medicine” and an active member of several additional associations and organizations.